Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
株式のランク #31271
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
株価
$4.02
時価総額
$13.51M
変化(1日)
1.77%
変化(1年)
86.11%
US
取引 GridAI Technologies Corp. (GRDX)

カテゴリー

GridAI Technologies Corp.(GRDX)のEPS
2026 時点のEPS TTM: 0
GridAI Technologies Corp.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
GridAI Technologies Corp.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS